Terazosin
- Product NDC
- 60760-316
- 11-digit product format
- 607600316
- Labeler code
- 60760
- Product ID
- 60760-316_affda9fa-33c8-d875-e053-2a95a90a6420
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2020-09-17
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-316-90 | 60760031690 | 90 CAPSULE in 1 BOTTLE, PLASTIC (60760-316-90) | 90 capsule | 2020-09-17 | 0000-00-00 | No | No | Current |